PolyBio
3/ The trial is currently divided into two phases: a randomized, controlled phase; and an open-label phase. Even if assigned to placebo initially, all participants will receive the option to trial the drug during the later open-label phase. Study rationale: https://polybio.org/projects/long-covid-low-dose-rapamycin-clinical-trial/